PD Dr. Gunnar Schley

Department of Medicine 4 – Nephrology and Hypertension

No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats (2023) Hartner A, Dambietz T, Cordasic N, Willam C, Burzlaff N, Brötsch M, Daniel C, et al. Journal article Strikingly conserved gene expression changes of polyamine regulating enzymes among various forms of acute and chronic kidney injury (2023) Sieckmann T, Schley G, Ögel N, Kelterborn S, Boivin FJ, Fähling M, Ashraf MI, et al. Journal article Reconfiguration and loss of peritubular capillaries in chronic kidney disease. (2023) Gaupp CS, Schmid B, Tripal P, Edwards A, Daniel C, Zimmermann S, Goppelt-Strübe M, et al. Journal article A PHD inhibitor prevents changes in the phosphoproteome and capillary rarefaction by CsA: treatment option for CKD? (2022) Schley G, Goppelt-Strübe M Journal article Dysregulation of the polyamine system in favour of its catabolism is a common mechanism after kidney injury (2022) Sieckmann T, Ogel N, Kelterborn S, Boivin F, Schley G, Fahling M, Ashraf MI, et al. Conference contribution Different Murine Models of Kidney Injury Reveal a Common Pattern of Dysregulation within the Polyamine System in Favour of its Catabolic Pathways (2022) Sieckmann T, Ögel N, Kelterborn S, Boivin FJ, Schley G, Fähling M, Ashraf MI, et al. Journal article The prolyl hydroxylase inhibitor molidustat fails to restore erythropoietin production in the fibrotic kidney (2022) Schley G, Hartner A Journal article Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys (2021) Broeker KAE, Fuchs MAA, Schrankl J, Lehrmann C, Schley G, Todorov VT, Hugo C, et al. Journal article Intravenous fluid therapy and acute kidney injury - What's new? (2021) Willam C, Schley G Journal article „Intravasal trocken – Gewebe voll“: interstitielles Ödem und Volumenmanagement in der Intensivmedizin (2021) Schley G, Willam C Journal article, Review article